![Reinhard Meier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Niklas Kouparanis | M | - |
Bloomwell Group GmbH
![]() Bloomwell Group GmbH Pharmaceuticals: OtherHealth Technology Bloomwell Group GmbH is a holding German company for medical cannabis companies and potentially for companies in a recreational market that may be legal in the future. The company is based in Frankfurt, Germany. The company's mission is to build, acquire and invest in ESG healthcare companies along the entire value chain, with the exception of cultivation. Bloomwell Group relies on a patient-centric D2C approach to set up a strong, revolutionizing and streamlined patient journey to change healthcare for the better. The company was founded in 2020 by Niklas Kouparanis, Samuel Menghistu. Niklas Kouparanis has been the CEO since 2020. | 4 years |
Samuel Menghistu | M | - |
Bloomwell Group GmbH
![]() Bloomwell Group GmbH Pharmaceuticals: OtherHealth Technology Bloomwell Group GmbH is a holding German company for medical cannabis companies and potentially for companies in a recreational market that may be legal in the future. The company is based in Frankfurt, Germany. The company's mission is to build, acquire and invest in ESG healthcare companies along the entire value chain, with the exception of cultivation. Bloomwell Group relies on a patient-centric D2C approach to set up a strong, revolutionizing and streamlined patient journey to change healthcare for the better. The company was founded in 2020 by Niklas Kouparanis, Samuel Menghistu. Niklas Kouparanis has been the CEO since 2020. | 4 years |
Boris Jordan | - | - |
Bloomwell Group GmbH
![]() Bloomwell Group GmbH Pharmaceuticals: OtherHealth Technology Bloomwell Group GmbH is a holding German company for medical cannabis companies and potentially for companies in a recreational market that may be legal in the future. The company is based in Frankfurt, Germany. The company's mission is to build, acquire and invest in ESG healthcare companies along the entire value chain, with the exception of cultivation. Bloomwell Group relies on a patient-centric D2C approach to set up a strong, revolutionizing and streamlined patient journey to change healthcare for the better. The company was founded in 2020 by Niklas Kouparanis, Samuel Menghistu. Niklas Kouparanis has been the CEO since 2020. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Germany | 3 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Reinhard Meier
- Personal Network